Research to Prevent Blindness
14
1
1
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
7.1%
1 terminated/withdrawn out of 14 trials
92.3%
+5.8% vs industry average
29%
4 trials in Phase 3/4
50%
6 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Parasitic Ulcer Treatment Trial Pilot
Role: collaborator
Mechanisms of Visual Restoration After Occipital Stroke
Role: collaborator
The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program
Role: collaborator
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
Role: collaborator
Primary Tube Versus Trabeculectomy Study
Role: collaborator
DNase Treatment for Dry Eyes
Role: collaborator
A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers
Role: collaborator
Ahmed Versus Baerveldt Comparison Study
Role: collaborator
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity
Role: collaborator
Effect of Nitrous Oxide (N2O) on Intraocular Pressure in Healthy Volunteers
Role: collaborator
Prospective Comparison of Cirrus Versus Stratus Ocular Coherence Tomography for Different Retinal Pathology.
Role: collaborator
Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery
Role: collaborator
Improving Vision and Quality of Life in the Nursing Home
Role: collaborator
Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs
Role: collaborator
All 14 trials loaded